Ocular melanoma: relatively rare but requiring respect

Clinics in Dermatology

Volumn 27, Issue 1, 2009, Pages 122-133

  Shields, Carol L ^a   Shields, Jerry A ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; COBALT 60; IODINE 125; MITOMYCIN C; RUTHENIUM 106; VERTEPORFIN;

ARTICLE; BRACHYTHERAPY; CHOROID MELANOMA; CLINICAL FEATURE; CONJUNCTIVA MELANOMA; DISEASE PREDISPOSITION; ENUCLEATION; EYE EXAMINATION; EYELID MELANOMA; HUMAN; IRIS MELANOMA; LASER COAGULATION; MELANOMA; MELANOSIS; OPHTHALMOSCOPY; ORBIT MELANOMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGNOSIS; TRANSPUPILLARY THERMOTHERAPY; UVEA MELANOMA;

EYE NEOPLASMS; HUMANS; MELANOMA; PROGNOSIS;

EID: 57449091278     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2008.09.010     Document Type: Article

References (53)

1. Shields J.A., and Shields C.L. Atlas of intraocular tumors (1999), Lippincott Williams and Wilkins, Philadelphia 74-150
2. Shields J.A., and Shields C.L. Intraocular tumors: a text and atlas (1992), WB Saunders, Philadelphia 117-206
3. Yu G.P., Hu D.N., McCormick S., and Finger P.T. Conjunctival melanoma: is it increasing in the United States?. Am J Ophthalmol 135 (2003) 800-806
4. Chan F.M., O'Donnell B.A., Whitehead K., et al. Treatment and outcomes of malignant melanoma of the eyelid: a review of 29 cases in Australia. Ophthalmology 114 (2007) 187-192
5. Shields J.A., and Shields C.L. Orbital malignant melanoma. The 2002 Sean B. Murphy Lecture. Ophthal Plast Reconstr Surg 19 (2003) 62-69
6. Shields C.L., Shields J.A., Gross N., et al. Survey of 520 eyes with uveal metastases. Ophthalmology 104 (1997) 1265-1276
7. de Bustros S., Augsburger J.J., Shields J.A., et al. Intraocular metastases from cutaneous malignant melanoma. Arch Ophthalmol 103 (1985) 937-940
8. Shields C.L., Shields J.A., Materin M., et al. Iris melanoma: risk factors for metastasis in 169 consecutive patients. Ophthalmology 108 (2001) 172-178
9. Li W., Judge H., Gragoudas E.S., et al. Patterns of tumor initiation in choroidal melanoma. Cancer Res 60 (2000) 3757-3760
10. Singh A.D., De Potter P., Fijal B.A., et al. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology 105 (1998) 195-198
11. Sumich P., Mitchell P., and Wang J.J. Choroidal nevi in a white population: The Blue Mountains Eye Study. Arch Ophthalmol 116 (1998) 645-650
12. Ganley J.P., and Comstock G.W. Benign nevi and malignant melanomas of the choroid. Am J Ophthalmol 76 (1973) 19-25
13. Singh A.D., Kalyani P., and Topham A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology 112 (2005) 1784-1789
14. Shields C.L., Shields J.A., Kiratli H., et al. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology 102 (1995) 1351-1361
15. Shields C.L., Cater J., Shields J.A., et al. Combination of clinical factors predictive of growth of small choroidal melanomcytic tumors. Arch Ophthalmol 118 (2000) 360-364
16. Weis E., Shah C.P., Lajous M., et al. The association of host susceptibility factors and uveal melanoma: a meta-analysis. Arch Ophthalmol 124 (2006) 54-60
17. Shah C.P., Weis E., Lajous M., et al. Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology 112 (2005) 1599-1607
18. Shields C.L., Shields J.A., DePotter P., et al. Diffuse choroidal melanoma: clinical features predictive of metastasis. Arch Ophthalmol 114 (1996) 956-963
19. Shields J.A., Mashayekhi A., Ra S., and Shields C.L. Pseudomelanomas of the posterior uveal tract. The 2006 Taylor Smith Lecture. Retina 25 (2005) 767-771
20. Prescher G., Bornfeld N., Hirche H., et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347 (1996) 1222-1225
21. Onken M.D., Worley L.A., Ehlers J.P., and Harbour J.W. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 64 (2004) 7205-7209
22. Shields C.L., Ganguly A., Materin M.A., et al. Chromosome 3 analysis of uveal melanoma using fine needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases. The Deborah Iverson MD Lectureship. Arch Ophthalmol 125 (2007) 1017-1024
23. Robertson D.M. Changing concepts in the management of choroidal melanoma. Am J Ophthalmol 136 (2003) 161-170
24. Shields C.L., Shields J.A., Gunduz K., et al. Radiation therapy for uveal malignant melanoma. Ophthalmic Surg Lasers 29 (1998) 397-409
25. Shields J.A., and Shields C.L. Surgical approach to lamellar sclerouvectomy for posterior uveal melanomas. The 1986 Schoenberg Lecture. Ophthalmic Surg 19 (1988) 774-780
26. Zimmerman L.E., McLean I.W., and Foster W.D. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells?. Br J Ophthalmol 62 (1978) 420-425
27. Seigel D., Myers M., Ferris F., and Steinhorn S.C. Survival rates after enucleation of eyes with malignant melanoma. Am J Ophthalmol 87 (1979) 751-765
28. Straatsma B.R., Fine S.L., Earle J.D., and The Collaborative Ocular Melanoma Study Research Group. Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology 95 (1988) 1000-1004
29. Straatsma B.R., Diener-West M., Caldwell R., Engstrom R.E., and Collaborative Ocular Melanoma Study Group. Mortality after deferral of treatment or no treatment for choroidal melanoma. Am J Ophthalmol 136 (2003) 47-54
30. Shields J.A., Glazer L.C., Mieler W.F., and Shields C.L. Comparison of xenon arc and argon laser photocoagulation in the treatment of choroidal melanomas. Am J Ophthalmol 109 (1990) 647-655
31. Barbazetto I.A., Lee T.C., Rollins I.S., et al. Treatment of choroidal melanoma using photodynamic therapy. Am J Ophthalmol 135 (2003) 898-899
32. Oosterhuis J.A., Journee-de Korver H.G., Kakebeeke-Kemme H.M., and Bleeker J.C. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 113 (1995) 315-321
33. Shields C.L., Shields J.A., Perez N., et al. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology 109 (2002) 225-234
34. Shields C.L., Cater J., Shields J.A., et al. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma in 270 consecutive patients. Arch Ophthalmol 120 (2002) 933-940
35. Shields C.L., Naseripour M., Cater J., et al. Plaque radiotherapy for large posterior uveal melanoma (>8 mm in thickness) in 354 consecutive patients. Ophthalmology 109 (2002) 1838-1849
36. Gragoudas E.S., Lane A.M., Munzenrider J., et al. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc 100 (2002) 43-48
37. The Collaborative Ocular Melanoma Study Group. The collaborative ocular melanoma study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10. Am J Ophthalmol 126 (1998) 779-796
38. The Collaborative Ocular Melanoma Study Group. The COMS randomized trial of Iodine 125 brachytherapy for choroidal melanoma. III: Initial mortality findings. COMS report no. 18. Arch Ophthalmol 119 (2001) 969-982
39. The Collaborative Ocular Melanoma Study Group. Factors predictive of growth and treatment of small choroidal melanoma. COMS report no. 5. Arch Ophthalmol 115 (1997) 1537-1544
40. Diener-West M., Hawkins B.S., Markowitz J.A., and Schachat A.P. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 110 (1992) 245-250
41. Eskelin S., Pyrhonen S., Summanen P., et al. Tumor doubling times in metastatic malignant melanoma of the uvea. Tumor progression before and after treatment. Ophthalmology 107 (2000) 1443-1449
42. Eskelin S., and Kivela T. Uveal melanoma: implications of tumor doubling time. [Author's reply]. Ophthalmology 108 (2001) 830-831
43. Shields C.L., Fasiudden A., Mashayekhi A., and Shields J.A. Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophthalmol 122 (2004) 167-175
44. Shields J.A., Shields C.L., Mashayekhi A., et al. Primary acquired melanosis of the conjunctiva. risks for transformation into melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture. Ophthalmology 115 (2008) 511-519.e2
45. Shields C.L. Conjunctival melanoma. [Editorial]. Br J Ophthalmol 86 (2002) 127
46. Shields J.A., and Shields C.L. Melanocytic tumors (of the conjunctiva). Atlas of eyelid and conjunctival tumors (1999), Lippincott Williams and Wilkins, Philadelphia 243-266
47. Shields C.L., Shields J.A., Gunduz K., et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 118 (2000) 1497-1507
48. Seregard S. Conjunctival melanoma. Surv Ophthalmol 42 (1998) 321-350
49. Esmaeli B., Eicher S., Popp J., et al. Sentinel lymph node biopsy for conjunctival melanoma. Ophthal Plast Reconstr Surg 17 (2001) 436-442
50. Shields J.A., and Shields C.L. Melanocytic tumors (of the eyelid). Atlas of eyelid and conjunctival tumors (1999), Lippincott Williams and Wilkins, Philadelphia 75-94
51. Shields J.A., and Shields C.L. Primary melanocytic tumors. Atlas of orbital tumors (1999), Lippincott Williams and Wilkins, Philadelphia 165-172
52. Shields J.A., Shields C.L., and Scartozzi R. Survey of 1264 orbital tumors and pseudotumors. The 2002 Montgomery Lecture. Part 1. Ophthalmology 111 (2004) 997-1008
53. Freedman M.I., and Folk J.C. Metastatic tumors to the eye and orbit. Patient survival and clinical characteristics. Arch Ophthalmol 105 (1987) 1215-1219